Profile picture

Doctor Ward Heggermont

Cardiovascular Research Center Aalst, Aalst (Belgium)
Membership: FESC Member
Follow
Biography
Ward Heggermont obtained his Medical Degree in 2009 at the Catholic University of Leuven (Belgium). After one year of clinical internship, he started his PhD thesis, sponsored by an FWO grant (Fonds Wetenschappelijk Onderzoek Vlaanderen (Belgium)), in October 2010, and succesfully obtained his PhD in 2016. He worked as a student-researcher in the Rega Institute (Leuven, Belgium), between 2004 and 2007. He has a particular interest in the overlapping scientific fields of Virology and Cardiology, and Metabolism. He worked on micro-RNAs involved in viral myocarditis, cardiac hypertrophy and heart failure. After a fellowship in Lugano (Prof. Dr. Angelo Auricchio) he now works as Full Staff Member at the Cardiovascular Center OLV Aalst, Belgium, and CARIM Maastricht, The Netherlands, with main interest in heart failure, cardiac resynchronization therapy, and cardio-oncology. He holds a degree in Specialized Medicine (MMed) and in Hospital Management (MSc).
Logo ESC

Contributor content

Prediction of HF events based on remote monitoring.
Presentation
Prediction of HF events based on remote monitoring.
Roudtable discussion.
Presentation
Roudtable discussion.
Managing heart failure patients with digital solutions.
Presentation
Managing heart failure patients with digital solutions.
Constrictive Pericarditis vs. Restrictive Cardiomyopathy: you don’t need to roll the dice.
Presentation
Constrictive Pericarditis vs. Restrictive Cardiomyopathy: you don’t need to roll the dice.
The MiR-221/-222 cluster is elevated both in biopsies of patients with myocarditis and idiopathic non-ischemic cardiomyopathy but fails to discriminate between both pathologies
Presentation
The MiR-221/-222 cluster is elevated both in biopsies of patients with myocarditis and idiopathic non-ischemic cardiomyopathy but fails to discriminate between both pathologies
MiR-126 is involved in allograft vasculopathy
Presentation
MiR-126 is involved in allograft vasculopathy
Serial endomyocardial microRNA-126 measurements in heart transplant recipients  with and without allograft vasculopathy.
Presentation
Serial endomyocardial microRNA-126 measurements in heart transplant recipients with and without allograft vasculopathy.
The microRNA-146a - DLST axis: a new therapeutic target in heart failure.
Presentation
The microRNA-146a - DLST axis: a new therapeutic target in heart failure.

ESC 365 is supported by